Innovating and collaborating in immuno-dermatology: a dialogue with ��ֳ�’s Simon Lucas & Camille Lee

Vandenbruaene Nathalie — Thu, 07 Mar 2024 09:30:58 +0000

Eimear O'Brien, Global Communications & Company Reputation

Vandenbruaene … Thu 07/03/2024 - 10:30

The 2024 American Academy of Dermatology (AAD) Annual Meeting takes place this week, in San Diego, California. We sat down with Simon Lucas, Global Head of Immuno-Dermatology, ��ֳ�, and Camille Lee, Head of U.S. Immunology, ��ֳ�, to learn more about ��ֳ�’s presence at the meeting and to hear their perspectives on the future of immuno-dermatology.

What can you tell us about the AAD Annual Meeting?

Camille – The 2024 AAD Annual Meeting is a highly anticipated event in the immuno-dermatology calendar. Organized by the American Academy of Dermatology, it is a platform for leading experts to disseminate cutting-edge research. This year, approximately 20,500 attendees from over 100 countries will convene in person to hear the latest developments in the diagnosis, prevention, and treatment of dermatologic conditions. ��ֳ� is a long-standing participant of AAD, and we are privileged to join the community again this year to stay up to date with the latest research and innovations.

Can you tell us about ��ֳ�’s presence at AAD 2024?

Simon – At AAD 2024, we have a strong scientific presence, showcasing sixteen abstracts across three disease areas – psoriasis, psoriatic arthritis and hidradenitis suppurativa. Given the chronic nature of these conditions, and the need for treatment options that provide lasting relief, we are pleased to unveil new four-year data in moderate-to-severe psoriasis and 48-week data in moderate-to-severe hidradenitis suppurativa.

Camille – In addition, delegates will have the opportunity to gain deeper insights into ��ֳ�’s portfolio at our exhibition booth. Healthcare professionals can also familiarize themselves with “Make HStory” our hidradenitis suppurativa disease awareness campaign that aims to bring more attention and awareness to this debilitating disease, as well as provide resources for HCPs and patients alike.

What is ��ֳ�’s current focus in immuno-dermatology?

Simon – We are focused on immuno-dermatological diseases characterized by substantial unmet needs. We have a solid history of connecting patients’ needs to innovative science and ultimately delivering new treatment options. Our mission is to deliver options and support that raise the standard of care, and we’re proud of our achievements so far. Our work is proceeding at a rapid pace. Recognizing that our aspirations cannot be realized alone, we actively collaborate with the community to advance our common goals. By working together today, we hope to improve the lives of more people living with immuno-dermatological conditions today and into the future.

How is ��ֳ� demonstrating its commitment to the community?

Camille – We are lucky to have a highly passionate team that is motivated each day by our company ethos “Inspired by patients. Driven by science.” Despite recent advances in therapy, people living with immuno-dermatological conditions still face significant unmet needs. That is why alongside our focus on developing new treatments, we partner and support causes that are important to the community. In the U.S., for example, our support of The HS Coalition, a leading group of patient advocates and healthcare professionals, showcases our commitment and how we strive to address disparities and improve outcomes in hidradenitis suppurativa. In addition, our collaboration with advocacy groups enables us to gain real-world insights that we use to help improve the lives of people with immuno-dermatologic diseases.

What do you envision for the future of immuno-dermatology?

Simon – We are in a significant era of scientific advancement in immuno-dermatology, where ground-breaking research is deepening our understanding of the skin immune response. The future is bright with science, innovation, and collaboration driving rapid advancement. With our existing portfolio and ongoing research in new disease areas and populations, ��ֳ� is proud to contribute and reinforce our commitment to the community.

Do you have a final message for delegates attending the meeting?

Camille – Patients are at the heart of everything we do at ��ֳ� and this year’s meeting offers an exciting opportunity to learn about the latest research, exchange ideas, and collectively shape the future of immuno-dermatology for patients. Through our work with those living with psoriasis and HS, we know that patients continue to need more support in managing their condition. We are excited to engage with attendees about how ��ֳ� can continue to help people living with immuno-dermatologic conditions. If you plan to attend, we invite you to visit our exhibition booth or join us at our scientific symposium. We look forward to connecting with you in San Diego. Safe travels!

��ֳ� has a proven heritage in immunology. We harness evidence-based science to deliver solutions and services that address persistent unmet needs across the healthcare ecosystem. By leveraging data, technology, and innovative scientific research we aim to improve the lives of people living with these diseases.

about ucb

137 Likes

��ֳ� at the 2022 AAD Annual Meeting: Our Commitment to Advancing Science in Dermatology

Vandenbruaene Nathalie — Thu, 24 Mar 2022 15:36:17 +0000

��ֳ� at the 2022 AAD Annual Meeting: Our Commitment to Advancing Science in Dermatology

Natalie Nunez-Gomez, Global Medical Affairs Psoriasis

Vandenbruaene … Thu 24/03/2022 - 16:36

Authors: Jeffrey Stark and Natalie Nunez Gomez, ��ֳ�

We are delighted to be joining leading skin specialists and research scientists at the 2022 American Academy of Dermatology (AAD) Annual Meeting (25-29 March) – the first ‘live’ AAD meeting in three years. What a difference it makes to be able to discuss the latest research, opportunities and challenges in person with our colleagues and friends in the dermatology community here in Boston. ��ֳ� is proud to contribute to the 2022 AAD Annual Meeting, with its extensive state-of-the-art research presentations and educational opportunities.

At this year’s meeting, we look forward to sharing important new scientific data from our clinical portfolio across 13 posters and one late-breaking oral presentation. These include new data focused on long-term complete skin clearance from our research programs on psoriasis – a life-long disease that affects approximately 125 million people worldwide.

Psoriasis is a common, chronic inflammatory disease mainly affecting the skin. Signs and symptoms can vary but may include red patches of skin covered with silvery scales; dry, cracked skin that may bleed; and thickened, pitted or ridged nails.

The wealth of scientific data we are presenting at the meeting underscores our commitment to achieving scientific advances in care and focusing on what matters most to people living with psoriasis.

At the meeting, ��ֳ� will also host an educational symposium “Under the Surface: Exploring the Pathophysiology and Unmet Needs in Patients with Psoriasis”. Speakers will share fresh insights into the underlying disease mechanisms of psoriasis and a deep understanding of patients’ desire to live the best life they can – as free as possible from the challenges and uncertainty of their condition.

We invite healthcare professionals attending the meeting to join our educational symposium and visit us at our exhibition booths where you will have the opportunity to meet members of our ��ֳ� team, discuss the latest research and explore further innovative approaches to help address the unmet needs of people with psoriasis.

We look forward to seeing you!

You can stay up to date with ��ֳ� news at the 2022 AAD Annual Meeting through our social media channels (Twitter, LinkedIn).

about ucb

AAD 2022 dermatology psoriasis American Academy of Dermatology Annual Meeting

602 Likes

American Academy of Dermatology Annual Meeting

Innovating and collaborating in immuno-dermatology: a dialogue with ��ֳ�’s Simon Lucas & Camille Lee

Leave a Comment

��ֳ� at the 2022 AAD Annual Meeting: Our Commitment to Advancing Science in Dermatology

Leave a Comment

American Academy of Dermatology Annual Meeting

Innovating and collaborating in immuno-dermatology: a dialogue with ������ֳ�’s Simon Lucas & Camille Lee

Leave a Comment

������ֳ� at the 2022 AAD Annual Meeting: Our Commitment to Advancing Science in Dermatology

Leave a Comment

Innovating and collaborating in immuno-dermatology: a dialogue with ��ֳ�’s Simon Lucas & Camille Lee

��ֳ� at the 2022 AAD Annual Meeting: Our Commitment to Advancing Science in Dermatology